Sorrento Therapeutics Inc
NASDAQ:SRNE
Cash Flow Statement
Cash Flow Statement
Sorrento Therapeutics Inc
Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|
Operating Cash Flow | ||||
Net Income |
(314)
|
(429)
|
(578)
|
|
Depreciation & Amortization |
11
|
12
|
13
|
|
Other Non-Cash Items |
140
|
138
|
201
|
|
Cash Taxes Paid |
0
|
1
|
0
|
|
Cash Interest Paid |
3
|
1
|
1
|
|
Change in Working Capital |
4
|
(3)
|
70
|
|
Cash from Operating Activities |
(160)
N/A
|
(282)
-77%
|
(294)
-4%
|
|
Investing Cash Flow | ||||
Capital Expenditures |
(7)
|
(9)
|
(14)
|
|
Other Items |
(33)
|
89
|
(15)
|
|
Cash from Investing Activities |
(40)
N/A
|
80
N/A
|
(29)
N/A
|
|
Financing Cash Flow | ||||
Net Issuance of Common Stock |
416
|
217
|
404
|
|
Net Issuance of Debt |
(187)
|
(36)
|
(92)
|
|
Other |
(55)
|
0
|
0
|
|
Cash from Financing Activities |
174
N/A
|
181
+4%
|
312
+72%
|
|
Change in Cash | ||||
Effect of Foreign Exchange Rates |
1
|
1
|
(2)
|
|
Net Change in Cash |
(24)
N/A
|
(20)
+19%
|
(13)
+34%
|
|
Free Cash Flow | ||||
Free Cash Flow |
(166)
N/A
|
(291)
-75%
|
(308)
-6%
|